BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 23525963)

  • 1. Molecular dynamic simulations give insight into the mechanism of binding between 2-aminothiazole inhibitors and CDK5.
    Wang W; Cao X; Zhu X; Gu Y
    J Mol Model; 2013 Jun; 19(6):2635-45. PubMed ID: 23525963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding mechanism of CDK5 with roscovitine derivatives based on molecular dynamics simulations and MM/PBSA methods.
    Dong K; Wang X; Yang X; Zhu X
    J Mol Graph Model; 2016 Jul; 68():57-67. PubMed ID: 27371933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery and optimization of triazine derivatives as ROCK1 inhibitors: molecular docking, molecular dynamics simulations and free energy calculations.
    Shen M; Zhou S; Li Y; Pan P; Zhang L; Hou T
    Mol Biosyst; 2013 Mar; 9(3):361-74. PubMed ID: 23340525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular dynamic simulations reveal the mechanism of binding between xanthine inhibitors and DPP-4.
    Gu Y; Wang W; Zhu X; Dong K
    J Mol Model; 2014 Feb; 20(2):2075. PubMed ID: 24481594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding Mechanism of Inhibitors to CDK5/p25 Complex: Free Energy Calculation and Ranking Aggregation Analysis.
    Wu Q; Kang H; Tian C; Huang Q; Zhu R
    Mol Inform; 2013 Mar; 32(3):251-60. PubMed ID: 27481520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural basis of valmerins as dual inhibitors of GSK3β/CDK5.
    Li X; Wang X; Tian Z; Zhao H; Liang D; Li W; Qiu Y; Lu S
    J Mol Model; 2014 Sep; 20(9):2407. PubMed ID: 25142337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of CDK5 activation revealed by steered molecular dynamics simulations and energy calculations.
    Zhang B; Su ZC; Tay TE; Tan VB
    J Mol Model; 2010 Jun; 16(6):1159-68. PubMed ID: 20013135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deep insights into the mode of ATP-binding mechanism in Zebrafish cyclin-dependent protein kinase-like 1 (zCDKL1): A molecular dynamics approach.
    Rout AK; Dehury B; Maharana J; Nayak C; Baisvar VS; Behera BK; Das BK
    J Mol Graph Model; 2018 May; 81():175-183. PubMed ID: 29574323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Virtual screening, pharmacokinetics, molecular dynamics and binding free energy analysis for small natural molecules against cyclin-dependent kinase 5 for Alzheimer's disease.
    Shukla R; Singh TR
    J Biomol Struct Dyn; 2020 Jan; 38(1):248-262. PubMed ID: 30688165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Investigation of Molecular Docking and Molecular Dynamic Simulation on Imidazopyridines as B-Raf Kinase Inhibitors.
    Xie H; Li Y; Yu F; Xie X; Qiu K; Fu J
    Int J Mol Sci; 2015 Nov; 16(11):27350-61. PubMed ID: 26580609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel urushiol derivatives as HDAC8 inhibitors: rational design, virtual screening, molecular docking and molecular dynamics studies.
    Zhou H; Wang C; Deng T; Tao R; Li W
    J Biomol Struct Dyn; 2018 Jun; 36(8):1966-1978. PubMed ID: 28632421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computational Simulations Identified Two Candidate Inhibitors of Cdk5/p25 to Abrogate Tau-associated Neurological Disorders.
    Zeb A; Son M; Yoon S; Kim JH; Park SJ; Lee KW
    Comput Struct Biotechnol J; 2019; 17():579-590. PubMed ID: 31073393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of hydrophobic and hydrogen bonding interactions on the potency of ß-alanine analogs of G-protein coupled glucagon receptor inhibitors.
    Venugopal PP; Das BK; Soorya E; Chakraborty D
    Proteins; 2020 Feb; 88(2):327-344. PubMed ID: 31443129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural bioinformatics insights into ATP binding mechanism in zebrafish (Danio rerio) cyclin-dependent kinase-like 5 (zCDKL5) protein.
    Rout AK; Mishra J; Dehury B; Maharana J; Acharya V; Karna SK; Parida PK; Behera BK; Das BK
    J Cell Biochem; 2019 Jun; 120(6):9437-9447. PubMed ID: 30569538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, virtual screening, molecular docking and molecular dynamics studies of novel urushiol derivatives as potential HDAC2 selective inhibitors.
    Zhou H; Wang C; Ye J; Chen H; Tao R
    Gene; 2017 Dec; 637():63-71. PubMed ID: 28939339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A computational insight into binding modes of inhibitors XD29, XD35, and XD28 to bromodomain-containing protein 4 based on molecular dynamics simulations.
    Su J; Liu X; Zhang S; Yan F; Zhang Q; Chen J
    J Biomol Struct Dyn; 2018 Apr; 36(5):1212-1224. PubMed ID: 28466681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Theoretical Studies on the Selectivity Mechanisms of Glycogen Synthase Kinase 3β (GSK3β) with Pyrazine ATP-competitive Inhibitors by 3DQSAR, Molecular Docking, Molecular Dynamics Simulation and Free Energy Calculations.
    Zhu J; Wu Y; Xu L; Jin J
    Curr Comput Aided Drug Des; 2020; 16(1):17-30. PubMed ID: 31284868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding the microscopic binding mechanism of hydroxylated and sulfated polybrominated diphenyl ethers with transthyretin by molecular docking, molecular dynamics simulations and binding free energy calculations.
    Cao H; Sun Y; Wang L; Zhao C; Fu J; Zhang A
    Mol Biosyst; 2017 Mar; 13(4):736-749. PubMed ID: 28217795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Probing Difference in Binding Modes of Inhibitors to MDMX by Molecular Dynamics Simulations and Different Free Energy Methods.
    Shi S; Zhang S; Zhang Q
    PLoS One; 2015; 10(10):e0141409. PubMed ID: 26513747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Definition of the binding mode of phosphoinositide 3-kinase α-selective inhibitor A-66S through molecular dynamics simulation.
    Bian X; Dong W; Zhao Y; Sun R; Kong W; Li Y
    J Mol Model; 2014 Apr; 20(4):2166. PubMed ID: 24633771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.